Wataru Makino

Wataru Makino

Auto-generated profile, based on publicly available information

Wataru Makino

Department of Radiation Oncology Central Japan International Medical Center Gifu Japan

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2021 in Journal of the Egyptian National Cancer Institute
Verified
Journal Article
Open access
PDF file
WMWataru Makino
Wataru Makino
JHJoichi Heianna
Joichi Heianna
KIKazuki Ishikawa
Kazuki Ishikawa
TKTakeaki Kusada
Takeaki Kusada
HMHitoshi Maemoto
Hitoshi Maemoto
SMSadayuki Murayama
Sadayuki Murayama
Background: Postoperative chemoradiotherapy is recommended for patients with head and neck squamous cell carcinoma with positive margins or extracapsular extension at high risk of recurrence. However, high-dose radiotherapy in the head and neck region often causes severe acute and late radiation-related adversities. In our institution, the radiation dose has been relatively lower than that used in Western countries to reduce radiation-related toxicities. Therefore, in this study, we examined the treatment outcomes of low-dose postoperative chemoradiotherapy. Methods: The outcomes of 90 consecutive head and neck squamous cell carcinoma patients who received postoperative radiotherapy between June 2009 and December 2016 were retrospectively analyzed. All patients received postoperative three-dimensional conformal radiotherapy with or without concurrent systemic chemotherapy. The median patient age was 65 years. Concurrent chemoradiotherapy was administered at a total dose of 50.4 Gy in 28 fractions (daily fraction, 1.8 Gy). High-risk patients received 10.8 Gy of boost irradiation in six fractions. For radiotherapy alone, the irradiation dose was up to 54 Gy in 30 fractions and 64.8 Gy in 36 fractions for high-risk patients to increase the treatment intensity. Results: The median follow-up period was 40.5 months. The 3-year locoregional control and overall survival rates were 67.5% and 82.7%, respectively. A significantly higher proportion of patients with oral cavity carcinoma experienced locoregional failure (p = 0.004). The acute adverse events were mild, and the only late adverse event was grade 3 dysphagia (n = 3). Conclusion: This study suggests that de-escalation of the postoperative radiation dose can potentially reduce the severe adverse events of irradiation in patients while ensuring its effectiveness. In patients with oral cavity carcinoma, it might be necessary to increase the radiation dose.

1 June 2022 in Auris Nasus Larynx
Verified
Journal Article
Closed access
JHJoichi Heianna
Joichi Heianna
WMWataru Makino
Wataru Makino
HHHitoshi Hirakawa
Hitoshi Hirakawa
SAShinya Agena
Shinya Agena
HTHayato Tomita
Hayato Tomita
SMSadayuki Murayama
Sadayuki Murayama

30 May 2025 in Head & Neck
Verified
Journal Article
Closed access
WMWataru Makino
Wataru Makino
NFNobukazu Fuwa
Nobukazu Fuwa
AMAkira Matsumoto
Akira Matsumoto
SOShinichi Ogawa
Shinichi Ogawa
YMYoshihito Matsui
Yoshihito Matsui
ATAkinori Takada
Akinori Takada

24 May 2019 in Radiology Case Reports
Verified
Journal Article
Open access
PDF file
WMWataru Makino
Wataru Makino
JHJoichi Heianna
Joichi Heianna
MTMasafumi Toguchi
Masafumi Toguchi
TTTaiki Teruya
Taiki Teruya
SMSadayuki Murayama
Sadayuki Murayama
Spinal metastasis is a rare presentation of paraganglioma and an effective therapy for nonresectable spinal metastatic paraganglioma (MPG) has not yet been established. We report the case of a 42-year-old woman with metastatic spinal cord compression caused by a relapsed spinal MPG after decompressive surgery. We performed transcatheter arterial embolization (TAE) in addition to systemic chemotherapy. After TAE, the neurologic symptoms improved, and the back pain was reduced. After 3 sessions of TAE, MRI revealed that the tumor at the level of the seventh thoracic vertebra had shrunk and the pressure on spinal cord had decreased. TAE might be a feasible treatment option for spinal MPG, even after surgery or irradiation.